Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 1405-41-0 | Product Number: G0383
Gentamicin Sulfate
×
Purity:
Synonyms:
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|
| 1G |
£27.00
|
7 | ≥100 |
|
|
| 5G |
£104.00
|
11 | Ships within 1 month after ordering |
|
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
Supplemental Product Information:
This product has not been tested and guaranteed for potency.
| Product Number | G0383 |
| Physical State (20 deg.C) | Solid |
Storage Temperature 
|
Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic,Heat Sensitive |
| Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 1405-41-0 |
| Related CAS RN
|
1403-66-3 |
| PubChem Substance ID | 160871021 |
| MDL Number | MFCD00270181 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Total Nitrogen | 8.0 to 10.0 % |
| Specific rotation [a]20/D | +107.0 to +121.0 deg(C=1, H2O)(calcd.on anh.substance) |
| Water | max. 18.0 % |
Properties (reference)
| Specific Rotation | 115° (C=1,H2O) |
| Solubility (insoluble in) | Ethanol, Ether |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary Statements | P261 : Avoid breathing dust. P280 : Wear protective gloves. P284 : Wear respiratory protection. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P304 + P340 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. |
Related Laws:
| EC Number | 215-778-9 |
| RTECS# | LY2625000 |
Transport Information:
| HS Number | 2941900000 |
Application
Biofilm research
By comparing the results by different biofilm quantitation techniques, effect of gentamicin on biofilm formation in Staphylococcus aureus has been reported.1) According to the report, although the significance rate was low, exposure to sub-minimum inhibitory concentration (sub-MIC) doses of gentamicin showed to induce the biofilm-forming capacity of S. aureus via increasing the total biomass without affecting the bacterial growth of viable count.
(The product is for research purpose only.)
(The product is for research purpose only.)
Reference
- 1) Antimicrobial Sub-MIC induces Staphylococcus aureus biofilm formation without affecting the bacterial count
- The aminoglycosides
- Structural origins of gentamicin antibiotic action
- Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
- Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?
- Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery
Application
Gentamicin: An Aminoglycoside Antibiotic with Potent Bactericidal Activities
Gentamicin, an aminoglycoside antibiotic, is isolated from Micromonospora purpurea, a genus of Gram-positive bacteria. It consists of a mixture of three isomers, gentamicin C1, gentamicin C1a and gentamicin C2. Gentamicin interacts with the 30S subunit of prokaryotic ribosomes, and then it inhibits bacterial growth by inhibiting protein synthesis. Gentamicin has activity against mostly Gram-negative bacteria including Pseudomonas, Proteus, Serratia, and the Gram-positive Staphylococcus. But, it is not used for Pneumococcus, Hemolytic streptococci, Bacteroides, Rickettsia and fungus. Gentamicin is widely used because of its potent bactericidal activities and less bacterial resistance, but it is well known to cause nephrotoxicity and hypacusis.
References
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Enter TCI Product Number
Enter KISHIDA Product Number
4-5 alphanumeric characters before the hyphen
7 alphanumeric characters
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
• The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Incorrect Lot Number. Please input only the 7 alphanumeric characters.
• Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
• If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
• Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Incorrect Lot Number. Please input only the 7 alphanumeric characters.
The requested analytical chart is not available. Sorry for the inconvenience.